BioCentury-BayHelix China Healthcare Summit 2025 Details

From in-licensing to newcos, the cross-border deals coming out of Asia are reshaping the global biopharma landscape.Meet biopharma decision-makers and investors in Shanghai to discuss these cross-border opportunities and challenges, and get a firsthand look at China's life sciences ecosystem.Join BioCentury, BayHelix and Insights Partner McKinsey & Company in Shanghai to reinvent your China strategy, with:

• Two days of strategic panels tailored to help busy executives understand emerging opportunities and challenges in China
• 50+ Road Show presentations from China, Asia and Western biotechs and medtechs, selected by BioCentury
• Four days of C-level partnering: Two days in Shanghai + two days virtual
• Hybrid event: Attend in-person or virtually via the China Summit digital platform
• McKinsey & Company's 12th year as Insights Partner with an exclusive conference report on the latest trends and data shaping the biopharma and medtech industries in China